Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii

作者: Peng Wang , Sarah L. Bowler , Serena F. Kantz , Roberta T. Mettus , Yan Guo

DOI: 10.1128/JCM.01810-16

关键词:

摘要: Treatment options for infections due to carbapenem-resistant Acinetobacter baumannii are extremely limited. Minocycline is a semisynthetic tetracycline derivative with activity against this pathogen. This study compared susceptibility testing methods that used in clinical microbiology laboratories (Etest, disk diffusion, and Sensititre broth microdilution methods) of minocycline, tigecycline, doxycycline 107 A. isolates. Susceptibility rates determined the standard method using cation-adjusted Mueller-Hinton (MH) were 77.6% minocycline 29% doxycycline, 92.5% isolates had tigecycline MICs ≤2 μg/ml. Using MH agar from BD Oxoid, Etest 67.3% 52.3% 21.5% 18.7% 71% 29.9% respectively. With diffusion 82.2% 72.9% 34.6% respectively, μg/ml 46.7% 23.4% tigecycline. In comparison results, very major low (∼2.8%) all three drugs across methods, but error higher (∼5.6%), especially method. For minor ranged 14% 37.4%. 6.5% 69.2%. The majority errors susceptible results being reported as intermediate. strains, rare, overcalling strains intermediate or resistant occur frequently feasible laboratories.

参考文章(25)
A L Barry, L B Reller, G H Miller, J A Washington, F D Schoenknect, L R Peterson, R S Hare, C Knapp, Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. Journal of Clinical Microbiology. ,vol. 30, pp. 585- 589 ,(1992) , 10.1128/JCM.30.3.585-589.1992
E.V. Lemos, F.P. de la Hoz, T.R. Einarson, W.F. McGhan, E. Quevedo, C. Castañeda, K. Kawai, Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta‐analysis Clinical Microbiology and Infection. ,vol. 20, pp. 416- 423 ,(2014) , 10.1111/1469-0691.12363
Gerald Murray, Anton Peleg, Yohei Doi, Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Seminars in Respiratory and Critical Care Medicine. ,vol. 36, pp. 85- 98 ,(2015) , 10.1055/S-0034-1398388
C. Kulah, G. Celebi, E. Aktas, Z. Mengeloglu, F. Comert, H. Ankarali, Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest. Journal of Chemotherapy. ,vol. 21, pp. 390- 395 ,(2009) , 10.1179/JOC.2009.21.4.390
Thean Yen Tan, Lily Siew Yong Ng, Dorene Mei Mei Chen, Influence of different Mueller–Hinton agars and media age on Etest susceptibility testing of tigecycline Diagnostic Microbiology and Infectious Disease. ,vol. 68, pp. 93- 95 ,(2010) , 10.1016/J.DIAGMICROBIO.2010.05.001
L. Silvia Munoz-Price, Yovanit Fajardo-Aquino, Kristopher L. Arheart, Timothy Cleary, Dennise DePascale, Louis Pizano, Nicholas Namias, Jesabel I. Rivera, Jessica A. O’Hara, Yohei Doi, Aerosolization of Acinetobacter baumannii in a Trauma ICU Critical Care Medicine. ,vol. 41, pp. 1915- 1918 ,(2013) , 10.1097/CCM.0B013E31828A39C0
J. Alexander Viehman, M. Hong Nguyen, Yohei Doi, Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections Drugs. ,vol. 74, pp. 1315- 1333 ,(2014) , 10.1007/S40265-014-0267-8
L M McMurry, D A Aronson, S B Levy, Susceptible Escherichia coli cells can actively excrete tetracyclines. Antimicrobial Agents and Chemotherapy. ,vol. 24, pp. 544- 551 ,(1983) , 10.1128/AAC.24.4.544